Every year, our medications reach nearly 800 million patients worldwide, but many more people still lack access to essential treatments and healthcare. Novartis is fundamentally shifting the way we do business and reimagining how to expand patient access to critical healthcare innovations.
Through our Novartis Access Principles, we are committed to systematically integrating access strategies into how we research, develop and deliver medicines around the world. These strategies include adopting innovative pricing and access models, refocusing research and development based on society’s healthcare needs, and supporting approaches to strengthen healthcare systems.
Research and Development
We systematically assess our product portfolio against the unmet needs of underserved populations and integrate these needs, as appropriate, into our drug discovery and development strategy.
We work to make our medicines available by considering both effective affordability strategies and innovative solutions to disease management.
We seek opportunities to lower local barriers to healthcare delivery, working in collaboration with governments and other partners to support quality patient care in areas where we can have the greatest impact.